Gene Editing Market Synopsis:

Gene Editing Market Size Was Valued at USD 2.10 Billion in 2023, and is Projected to Reach USD 8.69 Billion by 2032, Growing at a CAGR of 17.10 % From 2024-2032.

The Gene Editing Market includes products utilizing gene editing technologies and tools in the modification of the gene sequence of living organisms with the purpose of producing suitable characteristics. These technologies are CRISPR, TALEN AND ZFN which help in modification of the DNA, finds applications in biotechnology, drug discovery, agriculture and medical science. The market covers a wide range of applications, including gene therapy and disease treatment, improvement in crop productivity and several others and depends on the continuous research the research and development in genomics.

The gene editing market has expanded mainly due to research on genomics and the development of new techniques. Gaining prominence in the recent past, strategies such as CRISPR-Cas9 genetic tools have made genetic edits cheaper and more accurate hence can be considered for a vast range of functions that include therapeutic uses and farming enhancements. People governments and organizations around the globe are also going for more spending on genomic research that is also helping the market to grow more.

The other key factor which is pulling the demand forward is the increasing prevalence of genetic diseases as well as the shift towards more specific treatments. Biotechnologies are innovating new ways for controlling genetic engineering through gene editing and their outcomes demonstrate a high chance for treating or eradicating diseases that result from mutations; thus the emphasis on research and clinical uses. In the context of agriculture, gene editing offer an option to breed crops that are resistant to pests, diseases and shocks, a key tool in feeding the world.

Gene Editing Market

Gene Editing Market Trend Analysis:

Growing Technology

  • Among these, the CRISPR technology is growing very popular because of its precision, applicability, and simplicity as compared to other genetic modeling techniques such as TALEN and ZFN. Currently this technology has been applied within diversified fields such as medicine and especially in gene therapy, farming and in the breeding of livestock as well as agricultural crop development. Further, gene-editing technologies for use in clinical trials and therapeutics are becoming a prominent trend since diseases once without cure can now be edited out.
  • Another big trend can be marked as increased regulatory and ethical concern regarding gene editing, particularly human germline editing. By enactment of increased advanced technology, the regulatory bodies have been compelled to participate in determination of ethical standards and coordination to the usage of gene editing technologies. Such a trend has also engendered debates on policy regimes of gene therapy treatments and in the agricultural domain as well.

Continued development of gene therapies

  • The main opportunity in the gene editing market is continued development of gene therapies for various diseases and genetic disorders, including orphan and hereditary diseases. Importantly, as the technology evolves, it can offer disease and treatment personalized according to each patient’s genetic makeup, thus fostering better therapeutic results. This opportunity is especially important in the pharmaceutical industry since gene editing may dramatically change the ways therapy and cure are developed.
  • In the sector of agriculture, the potential to improve crop yield, disease resistance and nutritional value of foods is expanding rapidly. While people around the world speak about food insecurity and food sustainability, crops improved by gene editing and resistant to climate change and pests could be seen as a way of providing food security. This presents gene editing a chance to play a critical role of addressing sustainable agriculture and food production.

Gene Editing Market Segment Analysis:

Gene Editing Market is Segmented on the basis of Technology, Application, End User, and Region

By Technology, CRISPR segment is expected to dominate the market during the forecast period

  • The Gene Editing market is primarily divided into the technology such as Sophthesis, TALEN, ZFN, and other. And the most utilized application is undoubtedly CRISPR technology which is known for simplicity and high accuracy when it comes to modifying genes, and mostly used in research and treatment. TALEN, and to some extent, ZFN are still employed for express purposes that cannot be achieved by other methods of genome editing. Other technologies are, newer, relatively techniques that are still under development but base editing and prime editing as techniques that offers to overcome some of the drawbacks of previous techniques.

Application, Cell & Gene Therapy segment expected to held the largest share

  • Across the industries, the top areas of application include cell and gene therapy, ag biotech and livestock, diagnostics and research and development. In cell and gene therapy, gene editing serves as the process of causing alteration in genes to cure a specific genetic disease through a genetic engineering technique. In agriculture, it is used to bring Gene modified crops with better traits and in diagnostics gene editing refers to identification and treatment of variation causing diseases. In research the technique helps in research on gene functions and in generating new treatment methods in medicine.

Gene Editing Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

  • Among all the regions of the world, the North American region holds the largest share in the Global Gene Editing market, backed up by its matured Biotechnology industry and rapid investment in genetic science. The biotechnology companies and research organisations enjoy a strong presence in the United States which is home to many biotechnology firms or institutions, and the FDA that regulates gene editing. Moreover, the region has experienced growth in technological advancement especially in health sector, also government funding on gene therapy has made this region to have a better market.
  • The factor of the quick expansion of CRISPR and other gene-editing technologies within trials and treatments, in addition to North Americas supportive regulatory system for medical advancements, also contribute to the regional market advantage. The universities and the research labs across this region, being focused in the field of genetics provides the leadership in gene editing applications for future, primarily in medical and agricultural fields.

Active Key Players in the Gene Editing Market:

  • Beam Therapeutics (USA)
  • Caribou Biosciences (USA)
  • Cellectis (France)
  • CRISPR Therapeutics (Switzerland)
  • Editas Medicine (USA)
  • Intellia Therapeutics (USA)
  • Moderna (USA)
  • Precision BioSciences (USA)
  • Recombinetics (USA)
  • Sangamo Therapeutics (USA)
  • Other Active Players

Gene Editing Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 2.10 Billion

Forecast Period 2024-32 CAGR:

17.10 %

Market Size in 2032:

USD 8.69 Billion

Segments Covered:

By Technology
  • CRISPR
  • TALEN
  • ZFN
  • Other Technologies

Application
  • Cell & Gene Therapy
  • Agriculture & Livestock, Diagnostics
  • Research & Development

End User
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

By Region
  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:
  • Technological Advancements and Investment in Gene Editing

Key Market Restraints:
  • CRISPR Technology and Ethical Considerations in Gene Editing

Key Opportunities:
  • Personalized Medicine and Agricultural Advancements with Gene Editing

Companies Covered in the report:
  • Editas Medicine (USA), CRISPR Therapeutics (Switzerland), Intellia Therapeutics (USA), Sangamo Therapeutics (USA), Cellectis (France), Precision BioSciences (USA), Caribou Biosciences (USA), Beam Therapeutics (USA), Recombinetics (USA), Moderna (USA) and Other Active Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Gene Editing Market by Technology
 4.1 Gene Editing Market Snapshot and Growth Engine
 4.2 Gene Editing Market Overview
 4.3 CRISPR
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 CRISPR: Geographic Segmentation Analysis
 4.4 TALEN
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 TALEN: Geographic Segmentation Analysis
 4.5 ZFN
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 ZFN: Geographic Segmentation Analysis
 4.6 Other Technologies
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Other Technologies: Geographic Segmentation Analysis

Chapter 5: Gene Editing Market by Application
 5.1 Gene Editing Market Snapshot and Growth Engine
 5.2 Gene Editing Market Overview
 5.3 Cell & Gene Therapy
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Cell & Gene Therapy: Geographic Segmentation Analysis
 5.4 Agriculture & Livestock
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Agriculture & Livestock: Geographic Segmentation Analysis
 5.5 Diagnostics
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Diagnostics: Geographic Segmentation Analysis
 5.6 Research & Development
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Research & Development: Geographic Segmentation Analysis

Chapter 6: Gene Editing Market by End User
 6.1 Gene Editing Market Snapshot and Growth Engine
 6.2 Gene Editing Market Overview
 6.3 Biotechnology & Pharmaceutical Companies
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Biotechnology & Pharmaceutical Companies: Geographic Segmentation Analysis
 6.4 Academic & Research Institutes
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Academic & Research Institutes: Geographic Segmentation Analysis
 6.5 Contract Research Organizations (CROs)
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Contract Research Organizations (CROs): Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Gene Editing Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions  
 7.2 EDITAS MEDICINE (USA)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 CRISPR THERAPEUTICS (SWITZERLAND)
 7.4 INTELLIA THERAPEUTICS (USA)
 7.5 SANGAMO THERAPEUTICS (USA)
 7.6 CELLECTIS (FRANCE)
 7.7 PRECISION BIOSCIENCES (USA)
 7.8 CARIBOU BIOSCIENCES (USA)
 7.9 BEAM THERAPEUTICS (USA)
 7.10 RECOMBINETICS (USA)
 7.11 MODERNA (USA)
 7.12 OTHER ACTIVE PLAYERS

Chapter 8: Global Gene Editing Market By Region
 8.1 Overview
 8.2. North America Gene Editing Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Technology
  8.2.4.1 CRISPR
  8.2.4.2 TALEN
  8.2.4.3 ZFN
  8.2.4.4 Other Technologies
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Cell & Gene Therapy
  8.2.5.2 Agriculture & Livestock
  8.2.5.3 Diagnostics
  8.2.5.4 Research & Development
  8.2.6 Historic and Forecasted Market Size By End User
  8.2.6.1 Biotechnology & Pharmaceutical Companies
  8.2.6.2 Academic & Research Institutes
  8.2.6.3 Contract Research Organizations (CROs)
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Gene Editing Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Technology
  8.3.4.1 CRISPR
  8.3.4.2 TALEN
  8.3.4.3 ZFN
  8.3.4.4 Other Technologies
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Cell & Gene Therapy
  8.3.5.2 Agriculture & Livestock
  8.3.5.3 Diagnostics
  8.3.5.4 Research & Development
  8.3.6 Historic and Forecasted Market Size By End User
  8.3.6.1 Biotechnology & Pharmaceutical Companies
  8.3.6.2 Academic & Research Institutes
  8.3.6.3 Contract Research Organizations (CROs)
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Russia
  8.3.7.2 Bulgaria
  8.3.7.3 The Czech Republic
  8.3.7.4 Hungary
  8.3.7.5 Poland
  8.3.7.6 Romania
  8.3.7.7 Rest of Eastern Europe
 8.4. Western Europe Gene Editing Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Technology
  8.4.4.1 CRISPR
  8.4.4.2 TALEN
  8.4.4.3 ZFN
  8.4.4.4 Other Technologies
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Cell & Gene Therapy
  8.4.5.2 Agriculture & Livestock
  8.4.5.3 Diagnostics
  8.4.5.4 Research & Development
  8.4.6 Historic and Forecasted Market Size By End User
  8.4.6.1 Biotechnology & Pharmaceutical Companies
  8.4.6.2 Academic & Research Institutes
  8.4.6.3 Contract Research Organizations (CROs)
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 The Netherlands
  8.4.7.5 Italy
  8.4.7.6 Spain
  8.4.7.7 Rest of Western Europe
 8.5. Asia Pacific Gene Editing Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Technology
  8.5.4.1 CRISPR
  8.5.4.2 TALEN
  8.5.4.3 ZFN
  8.5.4.4 Other Technologies
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Cell & Gene Therapy
  8.5.5.2 Agriculture & Livestock
  8.5.5.3 Diagnostics
  8.5.5.4 Research & Development
  8.5.6 Historic and Forecasted Market Size By End User
  8.5.6.1 Biotechnology & Pharmaceutical Companies
  8.5.6.2 Academic & Research Institutes
  8.5.6.3 Contract Research Organizations (CROs)
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Gene Editing Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Technology
  8.6.4.1 CRISPR
  8.6.4.2 TALEN
  8.6.4.3 ZFN
  8.6.4.4 Other Technologies
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Cell & Gene Therapy
  8.6.5.2 Agriculture & Livestock
  8.6.5.3 Diagnostics
  8.6.5.4 Research & Development
  8.6.6 Historic and Forecasted Market Size By End User
  8.6.6.1 Biotechnology & Pharmaceutical Companies
  8.6.6.2 Academic & Research Institutes
  8.6.6.3 Contract Research Organizations (CROs)
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkiye
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Gene Editing Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Technology
  8.7.4.1 CRISPR
  8.7.4.2 TALEN
  8.7.4.3 ZFN
  8.7.4.4 Other Technologies
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Cell & Gene Therapy
  8.7.5.2 Agriculture & Livestock
  8.7.5.3 Diagnostics
  8.7.5.4 Research & Development
  8.7.6 Historic and Forecasted Market Size By End User
  8.7.6.1 Biotechnology & Pharmaceutical Companies
  8.7.6.2 Academic & Research Institutes
  8.7.6.3 Contract Research Organizations (CROs)
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
 

Gene Editing Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 2.10 Billion

Forecast Period 2024-32 CAGR:

17.10 %

Market Size in 2032:

USD 8.69 Billion

Segments Covered:

By Technology
  • CRISPR
  • TALEN
  • ZFN
  • Other Technologies

Application
  • Cell & Gene Therapy
  • Agriculture & Livestock, Diagnostics
  • Research & Development

End User
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

By Region
  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:
  • Technological Advancements and Investment in Gene Editing

Key Market Restraints:
  • CRISPR Technology and Ethical Considerations in Gene Editing

Key Opportunities:
  • Personalized Medicine and Agricultural Advancements with Gene Editing

Companies Covered in the report:
  • Editas Medicine (USA), CRISPR Therapeutics (Switzerland), Intellia Therapeutics (USA), Sangamo Therapeutics (USA), Cellectis (France), Precision BioSciences (USA), Caribou Biosciences (USA), Beam Therapeutics (USA), Recombinetics (USA), Moderna (USA) and Other Active Players.

Frequently Asked Questions :

What would be the forecast period in the Gene Editing Market research report?
The forecast period in the Gene Editing Market research report is 2024-2032.
Who are the key players in the Gene Editing Market?
Editas Medicine (USA), CRISPR Therapeutics (Switzerland), Intellia Therapeutics (USA), Sangamo Therapeutics (USA), Cellectis (France), Precision BioSciences (USA), Caribou Biosciences (USA), Beam Therapeutics (USA), Recombinetics (USA), Moderna (USA) and Other Active Players.
What are the segments of the Gene Editing Market?
The Gene Editing Market is segmented into By Technology, Application, End User and region. By Technology, the market is categorized into CRISPR, TALEN, ZFN, Other Technologies. Application, the market is categorized into Cell & Gene Therapy, Agriculture & Livestock, Diagnostics, Research & Development. End User, the market is categorized into Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations (CROs). By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Russia, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
What is the Gene Editing Market?
The Gene Editing Market includes products utilizing gene editing technologies and tools in the modification of the gene sequence of living organisms with the purpose of producing suitable characteristics. These technologies are CRISPR, TALEN AND ZFN which help in modification of the DNA, finds applications in biotechnology, drug discovery, agriculture and medical science. The market covers a wide range of applications, including gene therapy and disease treatment, improvement in crop productivity and several others and depends on the continuous research the research and development in genomics.
How big is the Gene Editing Market?
Gene Editing Market Size Was Valued at USD 2.10 Billion in 2023, and is Projected to Reach USD 8.69 Billion by 2032, Growing at a CAGR of 17.10 % From 2024-2032.